Produktname:prop-2-enoyl chloride

IUPAC Name:prop-2-enoyl chloride

CAS:814-68-6
Molekulare Formel:C3H3ClO
Reinheit:95%+
Katalognummer:CM350755
Molekulargewicht:90.51

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM350755-1000g in stock Şƚ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:814-68-6
Molekulare Formel:C3H3ClO
Schmelzpunkt:-
SMILES-Code:C=CC(Cl)=O
Dichte:
Katalognummer:CM350755
Molekulargewicht:90.51
Siedepunkt:
Mdl-Nr.:
Lagerung:Keep in a tight container and store at 2°C~8°C,protect from light

Column Infos

MK-1084
Merck initiates Phase 3 clinical trial of MK-1084, an investigational oral KRAS G12C inhibitor, in combination with KEYTRUDA® (pembrolizumab) for first-line treatment of certain patients with metastatic non-small cell lung cancer. KRAS mutations are one of the most frequently observed mutations in human cancers, making them a crucial target for precision oncology therapy.
MK-1084 is an investigational, oral covalent inhibitor of KRAS G12C, that is found in about 14% of people with non-small cell lung cancer. MK-1084 is currently under Phase 1 evaluation as monotherapy and as combined therapies in patients with KRAS G12C mutant advanced solid tumors.